交易 T2 Biosystems, Inc. - TTOO CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.07 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
T2 Biosystems Inc ESG Risk Ratings
High Medium Low Negligible
“D”分數表示相對 ESG 表現較差,公開報告重要 ESG 數據的透明度不足。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 17, 2024 | 2.92 | -0.07 | -2.34% | 2.99 | 2.99 | 2.82 |
Apr 16, 2024 | 3.01 | 0.13 | 4.51% | 2.88 | 3.10 | 2.73 |
Apr 15, 2024 | 2.92 | -0.14 | -4.58% | 3.06 | 3.15 | 2.76 |
Apr 12, 2024 | 3.12 | 0.03 | 0.97% | 3.09 | 3.19 | 3.06 |
Apr 11, 2024 | 3.12 | 0.09 | 2.97% | 3.03 | 3.25 | 2.97 |
Apr 10, 2024 | 3.01 | 0.03 | 1.01% | 2.98 | 3.32 | 2.80 |
Apr 9, 2024 | 3.07 | 0.29 | 10.43% | 2.78 | 3.32 | 2.75 |
Apr 8, 2024 | 2.77 | -0.04 | -1.42% | 2.81 | 2.83 | 2.72 |
Apr 5, 2024 | 2.78 | -0.10 | -3.47% | 2.88 | 2.88 | 2.72 |
Apr 4, 2024 | 2.81 | 0.02 | 0.72% | 2.79 | 2.98 | 2.77 |
Apr 3, 2024 | 2.77 | -0.11 | -3.82% | 2.88 | 2.96 | 2.75 |
Apr 2, 2024 | 2.94 | 0.10 | 3.52% | 2.84 | 2.94 | 2.76 |
Apr 1, 2024 | 2.95 | -0.03 | -1.01% | 2.98 | 2.98 | 2.79 |
Mar 28, 2024 | 2.96 | 0.03 | 1.02% | 2.93 | 3.10 | 2.78 |
Mar 27, 2024 | 2.99 | 0.18 | 6.41% | 2.81 | 3.15 | 2.78 |
Mar 26, 2024 | 2.81 | -0.08 | -2.77% | 2.89 | 2.91 | 2.74 |
Mar 25, 2024 | 2.94 | 0.09 | 3.16% | 2.85 | 2.96 | 2.70 |
Mar 22, 2024 | 2.83 | -0.14 | -4.71% | 2.97 | 3.01 | 2.78 |
Mar 21, 2024 | 2.98 | -0.15 | -4.79% | 3.13 | 3.15 | 2.97 |
Mar 20, 2024 | 3.06 | -0.71 | -18.83% | 3.77 | 3.82 | 2.93 |
T2 Biosystems, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Tuesday, May 21, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q1 2024 T2 Biosystems Inc Earnings Release Q1 2024 T2 Biosystems Inc Earnings ReleaseForecast(預報) -返回 - |
Monday, August 5, 2024 | ||
時間 (UTC) 10:59 | 國家 US
| 事件 Q2 2024 T2 Biosystems Inc Earnings Release Q2 2024 T2 Biosystems Inc Earnings ReleaseForecast(預報) -返回 - |
Friday, September 13, 2024 | ||
時間 (UTC) 13:00 | 國家 US
| 事件 T2 Biosystems Inc Annual Shareholders Meeting T2 Biosystems Inc Annual Shareholders MeetingForecast(預報) -返回 - |
- 每年
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
總收入 | 28.058 | 18.13 | 8.335 | 10.5 | 4.666 |
收入 | 28.058 | 18.13 | 8.335 | 10.5 | 4.666 |
收入成本,共計 | 20.703 | 20.68 | 16.763 | 15.404 | 12.028 |
毛利 | 7.355 | -2.55 | -8.428 | -4.904 | -7.362 |
總營業費用 | 71.031 | 59.486 | 60.393 | 55.59 | 58.518 |
銷售/一般/行政費用,總計 | 28.527 | 20.787 | 27.304 | 25.697 | 22.757 |
研究與開發 | 21.801 | 16.919 | 16.326 | 14.489 | 23.733 |
營業收入 | -42.973 | -41.356 | -52.058 | -45.09 | -53.852 |
利息收入(費用),非經營淨值 | -6.474 | -5.504 | -7.348 | -6.682 | -8.907 |
其他,淨值 | 0.206 | 0.062 | 0.4 | 0.619 | 0.331 |
稅前淨收入 | -49.241 | -46.798 | -59.006 | -51.153 | -62.428 |
稅後淨收入 | -49.241 | -46.798 | -59.006 | -51.153 | -62.428 |
未計算非常項目前的淨收益 | -49.241 | -46.798 | -59.006 | -51.153 | -62.428 |
淨收入 | -49.241 | -46.798 | -59.006 | -51.153 | -62.428 |
Total Adjustments to Net Income | |||||
普通股股東可獲收益 (不含非經常性項目) | -49.241 | -46.798 | -59.006 | -51.153 | -62.428 |
普通股股東可獲收益 (含非經常性項目) | -49.241 | -46.798 | -59.006 | -51.153 | -62.428 |
攤薄淨收入 | -49.241 | -46.798 | -59.006 | -51.153 | -62.428 |
攤薄後加權平均股 | 158.861 | 121.331 | 45.5078 | 40.5588 | 32.1315 |
扣除特別項目的每股攤薄盈利 | -0.30996 | -0.3857 | -1.29661 | -1.26121 | -1.94289 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
每股正常攤薄盈利 | -0.30996 | -0.37664 | -1.29661 | -1.26121 | -1.94289 |
異常費用(收入) | 1.1 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
總收入 | 7.234 | 6.98 | 7.428 | 6.694 | 6.956 |
收入 | 7.234 | 6.98 | 7.428 | 6.694 | 6.956 |
收入成本,共計 | 6.205 | 5.362 | 4.72 | 4.831 | 5.79 |
毛利 | 1.029 | 1.618 | 2.708 | 1.863 | 1.166 |
總營業費用 | 22.091 | 17.259 | 19.64 | 17.474 | 16.658 |
銷售/一般/行政費用,總計 | 9.23 | 6.544 | 8.536 | 7.244 | 6.203 |
研究與開發 | 6.356 | 5.353 | 6.384 | 5.399 | 4.265 |
Depreciation / Amortization | 0.3 | 0.4 | |||
營業收入 | -14.857 | -10.279 | -12.212 | -10.78 | -9.702 |
利息收入(費用),非經營淨值 | -1.647 | -1.86 | -1.913 | -1.694 | -1.007 |
其他,淨值 | 0.009 | -0.005 | 0.163 | -0.001 | 0.049 |
稅前淨收入 | -16.495 | -12.144 | -13.962 | -12.475 | -10.66 |
稅後淨收入 | -16.495 | -12.144 | -13.962 | -12.475 | -10.66 |
未計算非常項目前的淨收益 | -16.495 | -12.144 | -13.962 | -12.475 | -10.66 |
淨收入 | -16.495 | -12.144 | -13.962 | -12.475 | -10.66 |
普通股股東可獲收益 (不含非經常性項目) | -16.495 | -12.144 | -13.962 | -12.475 | -10.66 |
普通股股東可獲收益 (含非經常性項目) | -16.495 | -12.144 | -13.962 | -12.475 | -10.66 |
攤薄淨收入 | -16.495 | -12.144 | -13.962 | -12.475 | -10.66 |
攤薄後加權平均股 | 169.855 | 166.253 | 165.882 | 154.885 | 148.231 |
扣除特別項目的每股攤薄盈利 | -0.09711 | -0.07305 | -0.08417 | -0.08054 | -0.07191 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.09711 | -0.07305 | -0.08417 | -0.08054 | -0.07191 |
- 每年
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
流動資産總額 | 44.394 | 53.584 | 18.895 | 56.608 | 44.318 |
現金和短期投資 | 32.241 | 42.189 | 11.033 | 50.805 | 41.799 |
現金等價物 | 22.245 | 16.793 | 11.033 | 50.805 | 41.799 |
應收賬款總額,淨額 | 5.134 | 5.099 | 2.825 | 1.786 | 0.467 |
應收賬款 - 貿易,淨額 | 5.134 | 5.099 | 2.825 | 1.786 | 0.467 |
總庫存 | 3.909 | 3.636 | 3.599 | 2.677 | 1.344 |
預付的費用 | 3.11 | 2.66 | 1.438 | 1.34 | 0.708 |
總資産 | 60.539 | 79.078 | 28.486 | 64.309 | 54.861 |
物業/廠房/設備,總計 - 淨額 | 14.441 | 14.805 | 9.205 | 7.315 | 10.015 |
物業/廠房/設備,總計 - 總額 | 29.873 | 29.062 | 22.441 | 18.622 | 19.139 |
累計折舊,總計 | -15.432 | -14.257 | -13.236 | -11.307 | -9.124 |
其他長期資産,總計 | 1.704 | 0.687 | 0.386 | 0.386 | 0.528 |
流動負債總額 | 11.688 | 9.8 | 60.572 | 52.297 | 51.782 |
應付賬款 | 2.832 | 2.058 | 3.753 | 0.744 | 0.648 |
預提費用 | 8.338 | 7.512 | 11.207 | 6.073 | 6.218 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 0 | 42.902 | 42.373 | 40.696 | |
其他流動負債,總計 | 0.518 | 0.23 | 2.71 | 3.107 | 4.22 |
負債總額 | 73.442 | 70.352 | 62.491 | 52.922 | 53.521 |
長期債務總額 | 47.79 | 45.235 | 0 | 0 | 1.008 |
長期債務 | 47.79 | 45.235 | 0 | 1.008 | |
其他負債,總計 | 13.964 | 15.317 | 1.919 | 0.625 | 0.731 |
股權 | -12.903 | 8.726 | -34.005 | 11.387 | 1.34 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
普通股 | 0.166 | 0.148 | 0.051 | 0.044 | 0.036 |
額外實收資本 | 459.151 | 431.544 | 342.121 | 328.514 | 267.421 |
留存收益(累計赤字) | -472.216 | -422.975 | -376.177 | -317.171 | -266.117 |
總負債和股東權益 | 60.539 | 79.078 | 28.486 | 64.309 | 54.861 |
已發行普通股總數 | 166.401 | 148.079 | 50.6515 | 44.1754 | 35.9489 |
短期投資 | 9.996 | 25.396 | |||
長期投資 | 0 | 10.002 | |||
其他權益,總計 | -0.004 | 0.009 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
流動資産總額 | 33.503 | 44.394 | 54.46 | 63.859 | 44.587 |
現金和短期投資 | 19.386 | 32.241 | 42.089 | 52.788 | 33.308 |
現金等價物 | 9.397 | 22.245 | 22.047 | 32.708 | 10.691 |
短期投資 | 9.989 | 9.996 | 20.042 | 20.08 | 22.617 |
應收賬款總額,淨額 | 4.361 | 5.134 | 4.222 | 3.979 | 4.034 |
應收賬款 - 貿易,淨額 | 4.361 | 5.134 | 4.222 | 3.979 | 4.034 |
總庫存 | 5.172 | 3.909 | 4.822 | 4.784 | 4.525 |
預付的費用 | 4.584 | 3.11 | 3.327 | 2.308 | 2.72 |
總資産 | 49.039 | 60.539 | 70.037 | 78.898 | 70.052 |
物業/廠房/設備,總計 - 淨額 | 14.25 | 14.441 | 13.865 | 14.41 | 14.808 |
物業/廠房/設備,總計 - 總額 | 29.944 | 29.873 | 29.028 | 29.363 | 29.448 |
累計折舊,總計 | -15.694 | -15.432 | -15.163 | -14.953 | -14.64 |
長期投資 | 0 | 0 | 0 | 10.002 | |
其他長期資産,總計 | 1.286 | 1.704 | 1.712 | 0.629 | 0.655 |
流動負債總額 | 12.673 | 11.688 | 11.398 | 9.345 | 10.401 |
應付賬款 | 3.385 | 2.832 | 2.616 | 2.89 | 3.907 |
預提費用 | 8.95 | 8.338 | 8.169 | 6.017 | 6.094 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 0.338 | 0.518 | 0.613 | 0.438 | 0.4 |
負債總額 | 74.69 | 73.442 | 72.5 | 69.889 | 70.618 |
長期債務總額 | 48.257 | 47.79 | 47.132 | 46.487 | 45.855 |
長期債務 | 48.257 | 47.79 | 47.132 | 46.487 | 45.855 |
其他負債,總計 | 13.76 | 13.964 | 13.97 | 14.057 | 14.362 |
股權 | -25.651 | -12.903 | -2.463 | 9.009 | -0.566 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | |
普通股 | 0.171 | 0.166 | 0.166 | 0.165 | 0.148 |
額外實收資本 | 462.9 | 459.151 | 457.439 | 454.95 | 432.905 |
留存收益(累計赤字) | -488.711 | -472.216 | -460.072 | -446.11 | -433.635 |
其他權益,總計 | -0.011 | -0.004 | 0.004 | 0.004 | 0.016 |
總負債和股東權益 | 49.039 | 60.539 | 70.037 | 78.898 | 70.052 |
已發行普通股總數 | 171.413 | 166.401 | 165.968 | 165.764 | 148.492 |
- 每年
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
淨收入/起跑線 | -49.241 | -46.798 | -59.006 | -51.153 | -62.428 |
經營活動産生的現金 | -38.874 | -43.215 | -45.361 | -40.138 | -47.718 |
經營活動産生的現金 | 1.27 | 1.71 | 2.197 | 2.449 | 2.94 |
非現金物品 | 11.268 | 8.411 | 9.59 | 12.509 | 12.194 |
已付現金利息 | 3.814 | 3.692 | 4.659 | 3.786 | 3.959 |
營運資金的變化 | -2.171 | -6.538 | 1.858 | -3.943 | -0.424 |
投資活動産生的現金 | 24.791 | -36.261 | -0.761 | -0.593 | -2.476 |
資本支出 | -0.46 | -0.804 | -0.761 | -0.593 | -2.476 |
其他投資現金流量項目,總計 | 25.251 | -35.457 | 0 | ||
融資活動産生的現金 | 20.535 | 85.607 | 6.35 | 49.657 | 18.505 |
融資現金流項目 | 85.311 | 6.65 | 49.237 | 18.64 | |
股票的發行(報廢),淨額 | 20.535 | 0.296 | 0.582 | 1.967 | 1.059 |
債務的發行(退還),淨額 | 0 | -0.882 | -1.547 | -1.194 | |
現金淨變化 | 6.452 | 6.131 | -39.772 | 8.926 | -31.689 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -16.495 | -49.241 | -37.097 | -23.135 | -10.66 |
Cash From Operating Activities | -14.441 | -38.874 | -29.032 | -19.305 | -8.708 |
Cash From Operating Activities | 0.286 | 1.27 | 1 | 0.696 | 0.383 |
Non-Cash Items | 3.389 | 11.268 | 8.492 | 4.754 | 1.858 |
Cash Interest Paid | 1.106 | 3.814 | 2.815 | 2.815 | 0.928 |
Changes in Working Capital | -1.621 | -2.171 | -1.427 | -1.62 | -0.289 |
Cash From Investing Activities | -0.029 | 24.791 | 14.99 | 14.948 | 2.553 |
Capital Expenditures | -0.029 | -0.46 | -0.261 | -0.303 | -0.197 |
Other Investing Cash Flow Items, Total | 0 | 25.251 | 15.251 | 15.251 | 2.75 |
Cash From Financing Activities | 1.202 | 20.535 | 20.296 | 20.272 | 0.053 |
Issuance (Retirement) of Stock, Net | 1.432 | 20.535 | 20.296 | 20.272 | 0.053 |
Net Change in Cash | -13.268 | 6.452 | 6.254 | 15.915 | -6.102 |
Financing Cash Flow Items | -0.23 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Advanced Medical Equipment & Technology (NEC) |
101 Hartwell Ave
02421-3125
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易